Serum amyloid A (SAA) proteins were isolated and named over 50 years ago. They are
small (104 amino acids) and have a striking relationship to the acute phase response with …

Purpose A systematic literature review was done to determine the relationship between
elevated CRP and prognosis in people with solid tumors. C-reactive protein (CRP) is a …

Abstract Background Renal Cell Carcinoma (RCC) is difficult to treat with 5-year survival rate
of 10% in metastatic patients. Main reasons of therapy failure are lack of validated …

Urine is an ideal body fluid for the detection of protein markers produced by urological
cancers as it can be sampled noninvasively and contains secreted and directly shed …

Early detection, clinical management and disease recurrence monitoring are critical areas in
cancer treatment in which specific biomarker panels are likely to be very important in each of …

The quantification of plasma proteins using the high resolution and accurate mass (HR/AM)‐
based parallel reaction monitoring (PRM) method provides an immediate benefit over the …

Background Previous studies have demonstrated that serum amyloid A (SAA) levels are
correlated with the clinical outcomes of solid tumors. However, the available data have not …

Objective Increased serum amyloid A (SAA) levels have been investigated in various human
malignancies, but a consistent perspective has not been established to date. This study …

Gastric adenocarcinoma is an aggressive cancer with poor prognosis. Blood based
biomarkers of gastric cancer have the potential to improve diagnosis and monitoring of these …

Abstract Background Senescence-associated genes (SAGs) are responsible for the
senescence-associated secretory phenotype, linked in turn to cellular aging, the aging brain …